Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) for the treatment of resectable locally advanced (LA) head and neck squamous cell carcinoma (HNSCC): Phase 3 KEYNOTE-689 Meeting Abstract
| Authors: | Klochikhin, A.; Haddad, R. I.; Meirovitz, A.; Safina, S.; Brana, I.; Le Tourneau, C.; Uppaluri, R.; Lee, N. Y.; Cohen, E. E. W.; Chernock, R.; Westra, W.; Liu, H.; Gumuscu, B.; Benjamin, K.; Adkins, D.; Bowers, E. |
| Abstract Title: | Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) for the treatment of resectable locally advanced (LA) head and neck squamous cell carcinoma (HNSCC): Phase 3 KEYNOTE-689 |
| Meeting Title: | 49th Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 18 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Nov 2-4 |
| Meeting Location: | Brisbane, QLD, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2022-11-01 |
| Start Page: | 231 |
| End Page: | 232 |
| Language: | English |
| ACCESSION: | WOS:000871956500400 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.13869 |
| Notes: | Meeting Abstract: 448 -- This meeting abstract was published under the "Poster Abstracts" section of the issue -- Source: Wos |
